FDA inspection
Wugan Pharmaceutical (Suzhou) Co., Ltd.: FDA inspection ending Jul 19, 2019
FDA inspection 1098849 · No Action Indicated (NAI) · Suzhou
Key facts
| Inspection ID | 1098849 |
|---|---|
| Firm | Wugan Pharmaceutical (Suzhou) Co., Ltd. |
| FEI number | 3014390000 |
| Address | Tuncun Community, Wujiang, 159 Dongguan Road; Wujiang |
| City | Suzhou |
| Country | China |
| Fiscal year | 2019 |
| Inspection end date | Jul 19, 2019 |
| Classification | No Action Indicated (NAI) |
| Project area | Pre-Approval Eval. of Animal Drugs and Food Additives |
| Product type | Veterinary |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data